Literature DB >> 9059348

Fibrinogen and cardiovascular disease.

T W Meade1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9059348      PMCID: PMC499704          DOI: 10.1136/jcp.50.1.13

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  18 in total

1.  A six year prospective study of fibrinogen and other risk factors associated with mortality in stable claudicants.

Authors:  A K Banerjee; J Pearson; E L Gilliland; D Goss; J D Lewis; Y Stirling; T W Meade
Journal:  Thromb Haemost       Date:  1992-09-07       Impact factor: 5.249

2.  An international and interregional comparison of haemostatic variables in the study of ischaemic heart disease. Report of a working group.

Authors:  T W Meade; Y Stirling; S G Thompson; M V Vickers; L Woolf; A B Ajdukiewicz; G Stewart; J F Davidson; I D Walker; A S Douglas
Journal:  Int J Epidemiol       Date:  1986-09       Impact factor: 7.196

3.  Genetic and cultural inheritance of plasma fibrinogen concentration.

Authors:  A Hamsten; L Iselius; U de Faire; M Blombäck
Journal:  Lancet       Date:  1987-10-31       Impact factor: 79.321

4.  Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations.

Authors:  S E Humphries; M Cook; M Dubowitz; Y Stirling; T W Meade
Journal:  Lancet       Date:  1987-06-27       Impact factor: 79.321

5.  Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study.

Authors:  T W Meade; S Mellows; M Brozovic; G J Miller; R R Chakrabarti; W R North; A P Haines; Y Stirling; J D Imeson; S G Thompson
Journal:  Lancet       Date:  1986-09-06       Impact factor: 79.321

6.  Fibrinogen and risk of cardiovascular disease. The Framingham Study.

Authors:  W B Kannel; P A Wolf; W P Castelli; R B D'Agostino
Journal:  JAMA       Date:  1987-09-04       Impact factor: 56.272

7.  Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease.

Authors:  T W Meade; J Imeson; Y Stirling
Journal:  Lancet       Date:  1987-10-31       Impact factor: 79.321

8.  Haemostatic function and cardiovascular death: early results of a prospective study.

Authors:  T W Meade; W R North; R Chakrabarti; Y Stirling; A P Haines; S G Thompson; M Brozovié
Journal:  Lancet       Date:  1980-05-17       Impact factor: 79.321

9.  The influence of fibrinogen concentration on the development of vein graft stenoses.

Authors:  R C Hicks; M Ellis; R Mir-Hasseine; D J Higman; D Nott; R M Greenhalgh; J T Powell
Journal:  Eur J Vasc Endovasc Surg       Date:  1995-05       Impact factor: 7.069

10.  Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies.

Authors:  J W Yarnell; I A Baker; P M Sweetnam; D Bainton; J R O'Brien; P J Whitehead; P C Elwood
Journal:  Circulation       Date:  1991-03       Impact factor: 29.690

View more
  3 in total

1.  Atherosclerosis due to chronic arteritis caused by Chlamydia pneumoniae: a tentative hypothesis.

Authors:  W Stille; R Dittmann; G Just-Nübling
Journal:  Infection       Date:  1997 Sep-Oct       Impact factor: 3.553

2.  Prothrombin time derived fibrinogen determination on Sysmex CA-6000.

Authors:  A S Lawrie; S J McDonald; G Purdy; I J Mackie; S J Machin
Journal:  J Clin Pathol       Date:  1998-06       Impact factor: 3.411

Review 3.  [Arteriosclerosis as a sequela of chronic Chlamydia pneumoniae infection].

Authors:  W Stille; R Dittmann
Journal:  Herz       Date:  1998-05       Impact factor: 1.443

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.